Review
Published on 21 Feb 2025
Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1519428
Type at least 3 characters
1,607 articles
Articles
Original Research
Published on 21 Feb 2025
Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: an observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study)
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1532421
Original Research
Published on 19 Feb 2025
A retrospective study of neoadjuvant novel hormonal therapy prior to radical prostatectomy for high-risk prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1480861
- 340 views
Systematic Review
Accepted on 17 Feb 2025
The role of lymphadenectomy in the treatment of upper tract urothelial carcinoma: a systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1464587
Case Report
Published on 14 Feb 2025
Case report: A study on disease diagnosis and treatment outcome of a case of bilateral malignant solitary fibrous tumor of the kidneys
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1436015
- 126 views
Systematic Review
Accepted on 13 Feb 2025
Predictive factors of incidental prostate cancer in patients undergoing surgery for presumed benign prostatic hyperplasia: an updated systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1561675
- 110 views
Case Report
Published on 13 Feb 2025
Case report: Clinical and molecular features of renal gastrointestinal tumor
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1508600
- 246 views
Case Report
Published on 12 Feb 2025
Two rare cases of primary clear cell adenocarcinoma of the urethra: clinical experience, case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1539312
- 244 views
Case Report
Accepted on 10 Feb 2025
Solitary Testicular Metastasis Post-Prostatectomy for Prostatic Ductal Adenocarcinoma: Case Report and Literature Review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1464446
Original Research
Accepted on 10 Feb 2025
Aberrant expression of multiple -glutamyltransferases is associated with tumor progression and patient outcome in prostate cancers
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1518636
Systematic Review
Published on 10 Feb 2025
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settings
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1491314
- 571 views
Case Report
Accepted on 07 Feb 2025
Challenges in Diagnosing and Managing Sarcomatoid Urothelial Carcinoma of the Renal Pelvis: A Case Report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1480790
Systematic Review
Published on 07 Feb 2025
Association between the expression of specific microRNAs and prostate cancer progression- a systematic review and meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1481885
- 179 views
Review
Accepted on 06 Feb 2025
New biomarkers and multiplex tests for diagnosis of aggressive prostate cancer and therapy management
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1542511
Systematic Review
Accepted on 05 Feb 2025
Evolving Paradigms in Prostate Cancer Screening: A Decade of Bibliometric Insights and Technological Advancements
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1511880
Review
Published on 05 Feb 2025
Photodynamic therapy for the precise treatment of localized prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1454392
- 282 views